Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05829655

Measuring Acute Drug Demand in Humans

Conditions: Opioid Use Disorder, Opioid Dependence

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: EARLY_PHASE1
Enrollment: 75
Sponsor: University of Maryland, Baltimore

Location: General Clinical Research Center Baltimore Maryland

Summary

This research is being done to evaluate whether suvorexant may reduce the use of, subjective liking, and demand for various drugs.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 65 years old * Meets Diagnostic and Statistical Manual-5 criteria for Opioid Use Disorder (OUD) (moderate or severe) * Lifetime substance use history criterion \[blinded\] * Medically cleared to take suvorexant and blinded study medications * Be in good general health based on a physical examination, medical history, vital signs, and screening urine and blood tests Exclusion Criteria: * Pregnant or breast feeding * Seeking opioid use treatment * Significant mental health or physical disorder that is expected to interfere with study participation as assessed by the study physicians or medical staff * Known contraindications or allergies to suvorexant and/or the blinded study medications

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05829655). StuddyBuddy aggregates publicly available trial information.